Tranzyme Pharma Announces Top-Line Results of TZP-102 Phase 2b Trial

[at noodls] – Preliminary Analysis Indicates Trial Did Not Meet Primary Endpoint Tranzyme to Host Conference Call Today at 8:00 am ET RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), … more

View todays social media effects on OCRX

View the latest stocks trending across Twitter. Click to view dashboard